Search

everythinglearnresearchcommunity

for

Search:↓

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

The study found unique skin changes in a rare type of alopecia linked to a skin condition called linear morphea.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Ocimum oil may promote hair growth and reduce hair loss from cyclophosphamide.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Hair changes can indicate systemic diseases or medication effects.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Taxol damages hair growth cells, causing hair loss.

Scalp cooling does not stop hair loss from radiotherapy.

Some breast cancer patients treated with high-dose docetaxel may experience permanent hair loss.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

Vitamins A, B, C, and D are important for skin health and are being explored for new uses, but more research is needed to confirm their effectiveness.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Hair loss due to scalp metastasis from breast cancer, known as Neoplastic Alopecia, has a better survival rate than other scalp metastases and requires a biopsy for diagnosis.